Let’s work together and make great things happen.
Get in touchTarsadia
News and Blog
-
Payment Operations Software and the Transformation of the Payments Landscape
-
Payments software dooms incumbent processors
-
Tarsadia Leads the Charge as Thought Leader in Revolutionizing Payments
-
Kashiv BioSciences Enters into Exclusive Licensing Agreement with Alvotech for Development & Commercialization of a Proposed Biosimilar to Xolair® (omalizumab)
-
Payment Operations Software: The Multi-Hundred Billion Dollar Market to Optimize Payments
-
Tarsadia Strengthens Venture, Growth & Private Investing Practice with New Sector Heads
-
Kashiv Biosciences Announces Successful Phase 1 Study Results of ADL018, A Biosimilar Candidate to Xolair® (omalizumab)
-
Amneal Receives 505(b)(2) NDA Approval from FDA for PEMRYDI RTU®, a Ready-to-Use Oncology Injectable
-
Kashiv Biosciences Achieves Second U.S. Biosimilar Approval with FYLNETRA® (pegfilgrastim-pbbk)
-
Erasca To Present Promising Preliminary Herkules-3 Phase 1B Data At The 2023 ASCO Annual Meeting
-
Amneal Launches Third Biosimilar with FYLNETRA™ (pegfilgrastim-pbbk) in the United States
-
Erasca Reports First Quarter 2023 Financial Results and Business Updates
-
Part III – Digital Asset Technology: Institutional Trading Tools
-
Part II — Digital Asset Technology: Compliance and Security Tools
-
Amneal Reports First Quarter 2023 Financial Results
-
Digital Asset Technology: The Next Evolution of FinTech (Part I)
-
Healthcare Data: The Disruption Opportunity + Why This Time Is Different
-
Kashiv Biosciences Receives Approval for Its First Biosimilar RELEUKOTM (filgrastim-ayow)
-
Prolong Pharmaceuticals Announces Presentation of Phase 1 Data from HEMERA-1 Clinical Study of PP-007 in Patients with Acute Ischemic Stroke at the Late-Breaking Science Session, ISC 2023
-
Catalys Pacific Launches Kirilys Therapeutics as a Multi-asset Precision Oncology Company
-
Chronus Health Closes $22M Series A Financing Round
-
Petal nears unicorn status with fresh $140M in capital to upend ‘broken’ traditional credit system
-
AvantStay, a platform for kitting out — and then renting out — high-end vacation rental homes, raises $160M
-
Cue Health Confirms COVID-19 Tests Can Detect Omicron Variant
-
Yieldstreet Raises Strategic $50M Follow-On Led By Mayfair Equity Partners
-
How Asia’s Latest Insurtech Unicorn Is Transforming The Insurance Industry
-
Google’s provider of at-home Covid-19 tests is now a $3 billion company traded on Nasdaq
-
bolttech extends Series A funding round to US$210 million
-
LERETA Announces Sale to Flexpoint Ford and Vestar Capital Partners
-
Cambridge Mobile Telematics Acquires TrueMotion
-
Phil Announces up to $100M Strategic Growth Investment from Warburg Pincus, Fred Hassan to join Board of Directors
-
Yieldstreet raises $100M as it mulls going public via SPAC, eyes acquisitions
-
Cue Health Announces Completion of $235 Million Private Financing to Accelerate Growth
-
Petal Launches Prism Data To Offer Its Credit Technology To Other Firms
-
Holographic startup Envisics partners with Panasonic to fast-track in-car AR tech
-
LERETA Acquires Flood Determinations Business
-
British Company Envisics Is Bringing Augmented Reality to Your Windshield
-
Envisics nabs $50M for its in-car holographic display tech at a $250M+ valuation
-
LERETA Acquires Accumatch
-
When care becomes code
-
Specialty Prescription Management Provider Phil Secures $25MM in Series B Funding
-
FLEETCOR to Acquire Nvoicepay, a Leader in Full AP Automation Software
-
Investors Open Their Wallets For B2B Payments Efficiency